The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers;
The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers; ramie fibers; jute fibers; sisal fibers; flax fibers; soybean fibers; corn fibers; hemp fibers; lyocel fibers; wool; lactide and/or glycolide polymers; lactide/glycolide copolymers; silicate fibers; polyamide fibers; feldspar fibers; zeolite fibers, zeolite-containing fibers, acetate fibers; and combinations thereof; the hemostatic textile capable of activating hemostatic systems in the body when applied to a wound. Additional cofactors such as thrombin and hemostatic agents such as RL platelets, RL blood cells; fibrin, fibrinogen, and combinations thereof may also be incorporated into the textile. The invention is also directed to methods of producing the textile, and methods of using the textile to stop bleeding.
대표청구항▼
1. A packaged hemostatic textile comprising a textile material comprising glass fibers co-woven or knitted with secondary fibers, wherein said textile material is within a sterilized package, said glass fibers have a diameter from 5 nanometers to 15 microns, and said secondary fibers comprise raw or
1. A packaged hemostatic textile comprising a textile material comprising glass fibers co-woven or knitted with secondary fibers, wherein said textile material is within a sterilized package, said glass fibers have a diameter from 5 nanometers to 15 microns, and said secondary fibers comprise raw or regenerated bamboo fibers. 2. The packaged hemostatic textile of claim 1, wherein the glass fibers are in the warp and the secondary fibers are in the fill. 3. The packaged hemostatic textile of claim 1, wherein the textile material is capable of activating hemostatic systems in an animal when the textile material is applied to a wound. 4. The packaged hemostatic textile of claim 1, wherein the relative amounts of the glass fibers and the secondary fibers range from about 0.1% to about 99.9% by weight glass fibers and from about 99.9% to about 0.1% by weight secondary fibers, based on the total weight of the textile. 5. The packaged hemostatic textile of claim 1, wherein the relative amounts of the glass fibers and the secondary fibers range from about 50% to about 80% by weight glass fibers and from about 20% to about 50% by weight secondary fibers, based on the total weight of the textile. 6. The packaged hemostatic textile of claim 1, wherein the glass fibers comprise an alumino-borosilicate glass. 7. The packaged hemostatic textile of claim 1, wherein the raw or regenerated bamboo fibers comprise bamboo rayon fibers. 8. The packaged hemostatic textile of claim 1, wherein the package contains a wound dressing bandage comprising the textile material. 9. A packaged hemostatic textile comprising a textile material comprising glass fibers co-woven or knitted with secondary fibers, wherein said textile material is within a sterilized package, said glass fibers are continuous filaments, and said secondary fibers comprise raw or regenerated bamboo fibers. 10. The packaged hemostatic textile of claim 9, wherein the glass fibers have a diameter from 5 nanometers to 15 microns. 11. The packaged hemostatic textile of claim 9 or 6, wherein said raw or regenerated bamboo fibers comprise bamboo rayon fibers. 12. A packaged hemostatic textile comprising a textile material comprising glass fibers co-woven or knitted with secondary fibers, wherein said textile material is within a sterilized package and said secondary fibers comprise raw or regenerated bamboo fibers. 13. A hemostatic textile, comprising a textile material comprising glass fibers co-woven or knitted with raw or regenerated bamboo fibers, further comprising platelets bound to the glass fibers, the raw or regenerated bamboo fibers, or a combination thereof. 14. The hemostatic textile of claim 13, wherein the raw or regenerated bamboo fibers comprise bamboo rayon fibers. 15. The hemostatic textile of claim 13, wherein the relative amounts of the glass fibers and the raw or regenerated bamboo fibers range from about 65% by weight glass fibers and from about 35% by weight raw or regenerated bamboo fibers, based on the total weight of the textile. 16. A hemostatic textile comprising a textile material comprising glass fibers co-woven or knitted with raw or regenerated bamboo fibers, wherein the glass fibers have a diameter from 5 nanometers to 15 microns. 17. The hemostatic textile of claim 16, wherein the glass fibers comprise alumino-borosilicate glasses. 18. The hemostatic textile of claim 16, further comprising platelets bound to the glass fibers, the raw or regenerated bamboo fibers, or a combination thereof. 19. A hemostatic textile, comprising a textile material comprising glass fiber co-woven or knitted with raw or regenerated bamboo fibers, wherein when said textile material is in contact with a wound on an animal or human and blood from the wound, hemostatic systems are activated in the animal or human, and wherein the glass fibers have a diameter from 5 nanometers to 15 microns. 20. The hemostatic textile of claim 19, wherein the textile material is a nonwoven textile. 21. The hemostatic textile of claim 19, wherein the relative amounts of the glass fibers and the raw or regenerated bamboo fibers range from about 50% to about 80% by weight glass fibers and from about 20% to about 50% by weight raw or regenerated bamboo fibers, based on the total weight of the textile. 22. The hemostatic textile of claim 19, wherein the glass fibers comprise an alumino-borosilicate glass. 23. A hemostatic textile, comprising a textile material comprising glass fibers co-woven or knitted with raw or regenerated bamboo fibers, wherein when said textile material is in contact with a wound on an animal or human and blood from the wound, hemostatic systems are activated in the animal or human, and wherein the glass fibers are continuous filaments. 24. The hemostatic textile of claim 23, wherein the glass fibers have a diameter from 5 nanometers to 15 microns. 25. The hemostatic textile of claim 13, 16, 19, or 23, wherein said raw or regenerated bamboo fibers comprise bamboo rayon fibers. 26. A hemostatic textile, comprising a textile material comprising glass fibers co-woven or knitted with rayon fibers, wherein when said textile material is in contact with a wound on an animal or human and blood from the wound, hemostatic systems are activated in the animal or human, and wherein the textile material further comprises platelets bound to the glass fibers, rayon fibers, or a combination thereof. 27. A hemostatic textile comprising a textile material comprising glass fibers co-woven or knitted with secondary fibers, wherein the relative amounts of the glass fibers and the secondary fibers are 65% by weight glass fibers and 35% by weight secondary fibers, based on the total weight of the textile material. 28. The hemostatic textile of claim 27, wherein the secondary fibers comprise rayon fibers.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (34)
Sabatano Frank (1726 Colden Ave. Bronx NY 10462), Bandage that contains antiseptic.
Crowe, John H.; Crowe, Lois M.; Tablin, Fern; Wolkers, Willem F; Tsvetkova, Nelly M.; Oliver, Ann F., Erythrocytic cells and method for preserving cells.
Bode Arthur P. (Greenville NC) Heaton William A. L. (Norfolk VA) Holme Stein (Virginia Beach VA) Miller David T. (Parkland FL), Extended shelf life platelet preparations and process for preparing the same.
Rothwell, Stephen W.; Krishnamurti, Chitra; Reid, III, Thomas J., Fibrinogen bandages and arterial bleeding models and methods of making and using thereof.
Read Marjorie S. (Durham NC) Reddick Robert L. (Durham NC) Bode Arthur P. (Greenville NC), Pharmaceutically acceptable fixed-dried human blood platelets.
Brinkhous Kenneth M. (Chapel Hill NC) Read Marjorie S. (Durham NC), Reagents for screening tests and bioassay of von Willebrand\s factor (platelet aggregating factor) in blood plasmas.
Zimmermann Eberhard (Mnster-Nienberge DEX) Stroetmann Michael (Mnster DEX), Resorptive sheet material for closing and healing wounds and method of making the same.
Fischer, Thomas H.; Eskridge, Jr., E. Stan; Malloy, Jr., William M.; Evans, Malloy, Method for activating hemostatic systems by applying a hemostatic textile.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.